KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

NovoCure (NVCR) Shares Issued (2016 - 2025)

Historic Shares Issued for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $538000.0.

  • NovoCure's Shares Issued rose 43800.0% to $538000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 24355.23%. This contributed to the annual value of $4.1 million for FY2024, which is 6353.57% down from last year.
  • Latest data reveals that NovoCure reported Shares Issued of $538000.0 as of Q3 2025, which was up 43800.0% from $2.1 million recorded in Q2 2025.
  • NovoCure's Shares Issued's 5-year high stood at $8.7 million during Q2 2021, with a 5-year trough of $100000.0 in Q3 2024.
  • Over the past 5 years, NovoCure's median Shares Issued value was $2.2 million (recorded in 2024), while the average stood at $2.9 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 9591.25% in 2024, then surged by 236338.03% in 2025.
  • Over the past 5 years, NovoCure's Shares Issued (Quarter) stood at $1.5 million in 2021, then crashed by 35.85% to $952000.0 in 2022, then plummeted by 60.4% to $377000.0 in 2023, then skyrocketed by 420.69% to $2.0 million in 2024, then crashed by 72.59% to $538000.0 in 2025.
  • Its Shares Issued stands at $538000.0 for Q3 2025, versus $2.1 million for Q2 2025 and $5.2 million for Q1 2025.